Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Impact of Perinatal Exposure to Non-caloric Sweeteners on Food Preferences and Weight Gain in the First Year of Life

31 maj 2019 uppdaterad av: Martin Gotteland, University of Chile

Determination of Perinatal Exposure to Non-caloric Sweeteners. Implications for the Development of Preferences for Sweet Taste, and Weight Gain During the First Year of Life

During last years, non-caloric sweeteners (NCSs) have been increasingly incorporated into foodstuffs in replacement of sucrose in Chile. This situation has reached a point where it is currently difficult to find sugary foods without NCSs. As a result, the voluntary and involuntary consumption of these additives is growing significantly in the population, increasing the risk of exceeding the acceptable daily intake (ADI), especially for children. This situation is worrying as recent evidence suggests that NCSs are not inert in the body and can trigger adverse metabolic effects. For example, the consumption of beverages with NCSs has been shown to favor the development of obesity and type-2 diabetes in children and adults, and a recent study reported that the intake of NCSs during pregnancy was associated with a greater weight gain of the child at one year. It is likely that certain NCSs pass into the amniotic fluid and that the fetus is exposed to some of these compounds during pregnancy. This situation would persist in the infant through breast milk, as some studies detected sucralose and acesulfame-K in this fluid, even in mothers who claimed not to consume them. However, the real impact of NCS exposure during the neonatal period on the child health has been few studied. Therefore, the aim of this study is to determine the concentration of NCSs in samples of amniotic liquid and breastmilk and to correlate these data with the NCS intake by the mothers. Mothers/children will be classified in quintiles according to the results obtained. In the children from quintiles 1 and 5, we will also study whether neonatal exposure to NCSs may affect the sweet taste threshold and the preferences for this taste, the levels of salivary insulin and the weight gain in the first year. Breastmilk microbiota and child fecal microbiota will be also evaluated.

Studieöversikt

Studietyp

Observationell

Inskrivning (Förväntat)

315

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 40 år (Vuxen)

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Testmetod

Sannolikhetsprov

Studera befolkning

315 dyades mother/child recruited at the San Jose Hospital Maternity

Beskrivning

Inclusion Criteria:

  • Women with at least 36 weeks of gestation
  • Spanish-speaking
  • Elective cesarean delivery

Exclusion Criteria:

  • Multiple pregnancy
  • Type-2 diabetes
  • Intelectual disability
  • Presence of infectious disease compatible with chorio-amnionitis or immunosupression
  • Newborns with serious pathologies affecting their growth

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mothers with breastmilk NCSs
Tidsram: One month post-partum
Proportion of mothers with detectable NCSs in their breastmilk
One month post-partum

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mothers with amniotic liquid NCSs
Tidsram: At delivery
Proportion of mothers with detectable NCSs in their amniotic liquid
At delivery
Consumption of NCSs by the mothers
Tidsram: At recruitment (in the last month of pregnancy) and at 1 mont post-partum
Daily intake (mg/d) of sucralose, acesulfame-K, cyclamate, saccharin and stevia evaluated through a validated consumer trend survey
At recruitment (in the last month of pregnancy) and at 1 mont post-partum
Pregnancy complications
Tidsram: At delivery
Percentages of mothers with preclampsia, hypertension, gestacional diabetes, infections, or preterm labor
At delivery
Breastmilk concentrations of NCSs
Tidsram: One month post-partum
Concentrations of sucralose, acesulfame-K, cyclamate, saccharin, steviol in breastmilk samples
One month post-partum
Amniotic liquid concentrations of NCSs
Tidsram: At delivery
Concentrations of sucralose, acesulfame-K, cyclamate, saccharin, steviol in amniotic liquid samples
At delivery
Sweet taste of breastmilk
Tidsram: One month post-partum
Intensity (arbitrary units) of sweet taste in breast milk samples, as detected by e-tongue
One month post-partum
Sweet taste of amniotic liquid
Tidsram: At delivery
Intensity (arbitrary units) of sweet taste in amniotic liquid samples, as detected by e-tongue
At delivery
Threshold of sweet taste in children
Tidsram: 6 months
Determination of sweet taste threshold (lower concentration of sucrose detected) in children from quintiles 1 and 5 of classification according to the concentrations of NCS in breast milk that received
6 months
Food preferences in children
Tidsram: At 6 month of age
Food consumption in children from quintiles 1 and 5 of classification according to the concentrations of NCS in breast milk that receiveded,through a validated consumer trend survey
At 6 month of age
Salivary insulin in children
Tidsram: 6 months
Salivary concentration of insulin (pg/ml) in children from quintiles 1 and 5 of classification according to the concentrations of NCS in breast milk that they received
6 months
Infant gain weight
Tidsram: At 12 months
Changes in weight (kg) during the first year of life
At 12 months
Breast milk microbiota diversity
Tidsram: At one month post-partum
Intraindividual diversity of the breastmilk microbiota evaluated by Shannon index in samples from quintiles 1 and 5 of classification according to their NCS concentrations
At one month post-partum
Breast milk microbiota composition
Tidsram: At one month post-partum
Relative abundancies of the different bacterial taxa from the breastmilk microbiota, detected by high throughput sequencing, in samples from quintiles 1 and 5 of classification according to their NCS concentrations
At one month post-partum
Fecal microbiota diversity in children
Tidsram: At six months post-partum
Intraindividual diversity of the fecal microbiota, evaluated by Shannon index, in children from quintiles 1 and 5 of classification according to the concentrations of NCS in breast milk that they received
At six months post-partum
Fecal microbiota composition in children
Tidsram: At six months post-partum
Relative abundancies of the different bacterial taxa from the fecal microbiota, detected by high throughput sequencing, in children from quintiles 1 and 5 of classification according to the concentrations of NCS in breast milk that they received
At six months post-partum
Polymorphism of sweet taste receptor in children
Tidsram: At six months post-partum
Proportions of children presenting the different polymorphisms on the sweet taste receptor gene.
At six months post-partum

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Veronica Sambra, MaSc, University of Chile
  • Huvudutredare: Sandra Lopez, PhD, University of Chile
  • Huvudutredare: Paola Caceres, MaSc, University of Chile
  • Huvudutredare: Francisco Perez, PhD, University of Chile
  • Huvudutredare: Edgar Pastene, PhD, University of Concepción

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Förväntat)

1 juli 2019

Primärt slutförande (Förväntat)

1 juli 2020

Avslutad studie (Förväntat)

1 juli 2021

Studieregistreringsdatum

Först inskickad

30 maj 2019

Först inskickad som uppfyllde QC-kriterierna

31 maj 2019

Första postat (Faktisk)

3 juni 2019

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

3 juni 2019

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

31 maj 2019

Senast verifierad

1 maj 2019

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera